New research has found that Cannnabidiol is active against Gram-positive bacteria, including those responsible for many serious infections (such as Staphyloccocus aureus and Streptococcus pneumoniae), with potency similar to that of established antibiotics such as vancomycin or daptomycin.
The research is presented at ASM Microbe, the annual meeting of the American Society for Microbiology.
Cannabidiol, the main non-psychoactive chemical compound extracted from cannabis and hemp plants, has been approved by FDA for the treatment of a form of epilepsy, and is being investigated for a number of other medical conditions, including, anxiety, pain and inflammation. While there is limited data to suggest Cannabidiol can kill bacteria, the drug has not been thoroughly investigated for its potential as an antibiotic.
Work led by Dr Mark Blaskovich at The University of Queensland’s Institute for Molecular Bioscience’s Centre for Superbug Solutions, in collaboration with Botanix Pharmaceuticals Ltd, an early stage drug discovery company investigating topical uses of synthetic cannabidiol for a range of skin conditions, found that Cannabidiol was remarkably effective at killing a wide range of Gram-positive bacteria, including bacteria that have become resistant to other antibiotics, and did not lose effectiveness after extended treatment.
“Given cannabidiol’s documented anti-inflammatory effects, existing safety data in humans, and potential for varied delivery routes, it is a promising new antibiotic worth further investigation,” said Dr. Blaskovich. “The combination of inherent antimicrobial activity and potential to reduce damage caused by the inflammatory response to infections is particularly attractive.”
Importantly, the drug retained its activity against bacteria that have become highly resistant to other common antibiotics. Under extended exposure conditions that lead to resistance against vancomycin or daptomycin, Cannabidiol did not lose effectiveness. Cannabidiol was also effective at disrupting biofilms, a physical form of bacteria growth that leads to difficult-to-treat infections.
The project was co-funded by Botanix and Innovation Connections, an Australian government grant scheme to commercialize new products, processes and services. The paper will be presented on Sunday June 23rd from 11am-1 pm at the annual conference of the American Society for Microbiology, ASM Microbe 2019, at the Moscone Convention Center in San Francisco.
Learn more: Cannabidiol is a Powerful New Antibiotic
The Latest on: Cannnabidiol
via Google News
The Latest on: Cannnabidiol
- CBD Universe announces partnership with Spyder Active Sportson January 27, 2020 at 5:15 am
Each product is infused with CBD (cannabidiol) derived from hemp and combined with ingredients that are tough enough to withstand the elements and may aid in recovery. The collection includes: "Anyone ...
- How To Select An Ingredient Provider For Your Infused Cannabis And CBD Productson January 27, 2020 at 5:03 am
Choosing the right ingredient provider is an exciting step in bringing a CBD or THC product to market, but the stakes are high to make the right choice.
- Cannabidiol Nutraceuticals Market Size Worth $17.4 Billion By 2026: Grand View Research, Inc.on January 27, 2020 at 1:05 am
/PRNewswire/ -- The global CBD nutraceuticals market is projected to reach USD 17.4 billion by 2026, according to a new report by Grand View Research, Inc.
- Managing CBD maniaon January 26, 2020 at 11:20 pm
Billy Giron, who co-founded of The CBD Boutique back in August 2015, remembers starting with just $500 worth of products containing cannabidiol, a compound derived from the cannabis plant. He said the ...
- CBD products are everywhere in Texas since the state legalized hemp. Experts warn: buyer beware.on January 26, 2020 at 2:21 pm
No one wanted to talk about it. No one was interested in carrying this product in any sort of spa or retail space,” Kerver said. Today, the market for CBD, or cannabidiol, is exploding. Stores are ...
- Cannabidiol (CBD) Market In-Depth Analysis of Driving Factors and Challenges 2019 to 2016on January 23, 2020 at 4:12 am
The study delivers a comprehensive analysis of global cannabidiol (CBD) market by product, application and regions. The Global Cannabidiol (CBD) Market is anticipated to grow from USD 1,453.81 Million ...
- Tasmanian Alkaloids calls for legalisation of cannabidiolon January 22, 2020 at 6:01 pm
Tasmanian Alkaloids has called on the federal government to relax controls over cannabidiol (CBD) - a non-psychoactive chemical found in cannabis plants. A Senate inquiry was established last year to ...
- Global Cannabidiol Oil (CBD) Supplements Market 2020 Demand, Market Size, Share, Product Analysis, Regional Outlook and Forecast-2026on January 21, 2020 at 8:40 am
Supplements Market” WiseGuyRerports.com Presents "Global Cannabidiol Oil (CBD) Supplements Market Research Report 2020" New Document to ...
- Study: Cannabidiol may not ease sleep problems, especially for regular userson January 20, 2020 at 8:32 pm
(CNN) — If the weed Twitterverse is to be believed, a lot of marijuana users rely on a nightly puff or two to drift off into la-la land. And surveys of marijuana users show they do indeed rely on the ...
- Cannabidiol (CBD) Cosmetics Global Market Size, Share, Demand, Growth, Opportunities, Analysis of Top Key Player and Forecast to 2026on January 16, 2020 at 9:35 pm
Cosmetics” This report covers market characteristics, size and growth, segmentation, regional breakdowns, competitive landscape, market ...
via Bing News